Artelo Biosciences Inc. (ARTL) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Artelo Biosciences Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$2.33
+5.91% today
Market cap
$1M
Overall quality
55/100
Kronos AI 30-day
+165.6%
8 of 8 simulated paths end higher
Artelo Biosciences Inc. (ARTL) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $1M. It trades at $2.33, up 5.91% today. Its overall quality score is 55 out of 100, ranked against the whole US market. Kronos AI's 30-day forecast is +165.6% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $5.84 (+165.6%) |
| Likely range | +134.7% … +182.4% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 34 |
| Solvency | 93 |
| Growth | 39 |
| Overall | 55 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.